Insmed (INSM) Current Assets (2010 - 2026)
Insmed's Current Assets was $1.71 billion in Q3 2026, down 11.7% from $1.93 billion a year earlier but up 4.4% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Insmed came in at $1.79 billion, up 10.6% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 23.6% (FY2020 to FY2025).
- In earlier years, Current Assets was $1.62 billion in FY2024 (+74.5%), $929.06 million in FY2023 (-27.0%), $1.27 billion in FY2022 (+52.1%) and $837.04 million in FY2021 (+34.4%).
- Quarterly Current Assets has moved between $632.17 million (Q3 2022) and $2.08 billion (Q2 2025) over five years.
- Compared with a year earlier, Current Assets was higher in six of the last eight quarters, with growth averaging 27.0%.
- The best year-over-year quarter for Current Assets over five years was Q1 2025 (growth of 84.9%); the worst was Q2 2022 (a decline of 35.0%).
- Per Business Quant data, INSM's Current Assets in the three quarters before Q3 2026 was $1.63 billion (Q2 2026), $1.61 billion (Q1 2026) and $1.79 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Insmed | 25.82 Bn | 20.86 Bn | 446.21 Mn | 1.71 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.71 Bn |
| Jun 30, 2026 | 1.63 Bn |
| Mar 31, 2026 | 1.61 Bn |
| Dec 31, 2025 | 1.79 Bn |
| Sep 30, 2025 | 1.93 Bn |
| Jun 30, 2025 | 2.08 Bn |
| Mar 31, 2025 | 1.40 Bn |
| Dec 31, 2024 | 1.62 Bn |
| Sep 30, 2024 | 1.65 Bn |
| Jun 30, 2024 | 1.42 Bn |
| Mar 31, 2024 | 758.72 Mn |
| Dec 31, 2023 | 929.06 Mn |
| Sep 30, 2023 | 926.58 Mn |
| Jun 30, 2023 | 1.05 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.27 Bn |
| Sep 30, 2022 | 632.17 Mn |
| Jun 30, 2022 | 674.73 Mn |
| Mar 31, 2022 | 756.14 Mn |
| Dec 31, 2021 | 837.04 Mn |
API Access
Insmed Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();